Core Laboratories Balance Sheet Health
Financial Health criteria checks 3/6
Core Laboratories has a total shareholder equity of $200.2M and total debt of $180.4M, which brings its debt-to-equity ratio to 90.2%. Its total assets and total liabilities are $593.6M and $393.5M respectively. Core Laboratories's EBIT is $48.8M making its interest coverage ratio 3.9. It has cash and short-term investments of $16.3M.
Key information
90.2%
Debt to equity ratio
US$180.44m
Debt
Interest coverage ratio | 3.9x |
Cash | US$16.29m |
Equity | US$200.15m |
Total liabilities | US$393.47m |
Total assets | US$593.62m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CLB *'s short term assets ($227.9M) exceed its short term liabilities ($95.6M).
Long Term Liabilities: CLB *'s short term assets ($227.9M) do not cover its long term liabilities ($297.8M).
Debt to Equity History and Analysis
Debt Level: CLB *'s net debt to equity ratio (82%) is considered high.
Reducing Debt: CLB *'s debt to equity ratio has reduced from 155.1% to 90.2% over the past 5 years.
Debt Coverage: CLB *'s debt is not well covered by operating cash flow (9.1%).
Interest Coverage: CLB *'s interest payments on its debt are well covered by EBIT (3.9x coverage).